Dedicated and highly organized Medical Doctor with over 2 years of clinical experience and 1.5 years as a Drug Safety Associate. Certified in Advanced Pharmacovigilance and Drug Safety, ensuring compliance with FDA standards and other regulatory authorities. Expertise in signal detection, risk management, and drug vigilance activities, with a strong focus on aggregate reports tracking, including PSUR, PBRER, RMP, and signal detection activities.
Extensive knowledge of Good Clinical Practices (GCP) and Good Pharmacovigilance Practices (GPVP), coupled with experience in ICH-GCP guidelines. Proficient in safety database applications, MedDRA, and WHO Drug Coding, with a thorough understanding of 21 CFR Part 11 regulatory requirements. Well-versed in US and EU pharmacovigilance regulatory standards.
Skilled in evaluating, interpreting, and synthesizing scientific data of adverse and serious adverse events, as well as individual case safety reports (ICSRs). Hands-on experience with the Argus Safety Application and comprehensive knowledge of the PV case routing process from case book-in to submission in the Argus Global Safety application. Expertise in MedDRA coding of serious adverse events (SAEs) and adverse events (AEs), and experience in supporting regulatory inspections and audits.